Physician profile
Michael A Simon
NPI 1700885761
$2,917.85
in general payments reported to CMS, 2019-2025
28 companies · $552 in 2025
The $552 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $484 · 2021: $456 · 2022: $359 · 2023: $428 · 2024: $335 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $483.36 | 2019-2024 | Myrbetriq |
| Janssen Biotech, INC. | $461.88 | 2020-2025 | Erleada |
| Coloplast Corp | $414.47 | 2019-2025 | Speedicath, Self-Cath |
| Rochester Medical Corporation | $199.46 | 2020-2021 | |
| Pfizer INC. | $188.48 | 2019-2023 | |
| Becton, Dickinson and Company | $166.03 | 2025 | Hemosphere |
| Bayer Healthcare Pharmaceuticals INC. | $139.64 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $121.29 | 2019-2022 | |
| Boston Scientific Corporation | $81.59 | 2019-2021 | |
| Tolmar, INC. | $80.88 | 2023-2024 | |
| Teleflex LLC | $64.88 | 2021-2024 | Urolift |
| Antares Pharma, INC. | $62.79 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Axonics, INC. | $62.77 | 2020-2024 | Axonics |
| Myovant Sciences INC. | $43.53 | 2021 | |
| Laborie Medical Technologies Corp. | $37.42 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $34.27 | 2019 | |
| Abc Home Medical Supply, INC. | $33.12 | 2022 | |
| Blue Earth Diagnostics | $29.98 | 2024 | |
| 180 Medical, INC. | $26.45 | 2024 | |
| Urogen Pharma, INC. | $26.23 | 2025 | |
| Hologic Sales and Service, LLC | $23.43 | 2025 | Aptima |
| Urovant Sciences INC | $22.97 | 2021 | |
| Millicent US INC | $22.63 | 2024 | Femring, Intrarosa |
| Calyxo, INC. | $19.47 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $19.03 | 2025 | Provenge |
| Verity Pharmaceuticals INC. | $18.68 | 2025 | Tlando |
| Kowa Pharmaceuticals America, INC. | $18.08 | 2023 | Seglentis |
| Procept Biorobotics Corporation | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.